THC Tolerance Did Not Transfer Equally to Synthetic Cannabinoids in Monkeys

Tolerance to THC did not reduce sensitivity equally to every cannabinoid agonist in a rhesus-monkey experiment. The result concerns an internal drug-discrimination cue, not protection from the adverse effects of synthetic cannabinoid products.

The task compared trained drug cues

Monkeys were trained to distinguish intravenous THC from vehicle. Researchers then compared responses to THC and several synthetic agonists before and after repeated THC treatment. Substitution in this task means that a compound produced a sufficiently similar cue to guide the trained response.

Treatment duration changed the pattern

After three days, the abstract reports reduced sensitivity to THC without corresponding cross-tolerance to the tested synthetic agonists. After fourteen days, sensitivity declined to all of them, but the shift was greater for THC than for several higher-efficacy agonists.

Shared cues do not establish shared safety

Different receptor efficacy can help explain why compounds acting at CB1 receptors produce different adaptation patterns. It does not establish the toxicity of an unidentified retail mixture. Neither cue substitution nor tolerance demonstrates immunity to seizures, cardiovascular effects or impaired judgment.

The finding is especially relevant to claims that cannabis experience makes synthetic cannabinoids predictable. It provides evidence against a simple equal-transfer assumption. The injected exposure, animal training and selected compounds define the limits; no human driving test, clinical overdose comparison or blood impairment threshold was established.

Related: interpreting cannabis tolerance claims.

Research cited

Hruba L; Ginsburg BC; McMahon LR. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys. The Journal of pharmacology and experimental therapeutics (2012). doi:10.1124/jpet.112.196444. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

A female-rat feeding study found that THC increased fat intake in one access schedule while rimonabant reduced intake in another. The feeding history and experimental group mattered to the direction and persistence of the response. Limited access created different eating patterns Rats had unrestricted chow and water, with groups differing…

Spread the love

Read Article: THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

In a mouse THC study, mTOR inhibition prevented selected memory-related effects when given before exposure but did not prevent a residual cognitive deficit when introduced after chronic THC stopped. Timing changed the intervention's result. Acute effects separated by endpoint Temsirolimus prevented acute anxiety-like and amnesic-like effects. THC-related anxiolysis, hypothermia, reduced…

Spread the love

Read Article: mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

A mouse study found that repeated lower-dose JZL184 preserved antinociceptive and gastroprotective effects that became tolerant under higher-dose regimens. The result supports a dose-dependent experimental window, not a validated human treatment schedule. Two disease-related models were used Researchers examined neuropathic pain after sciatic nerve constriction and gastric hemorrhage induced by…

Spread the love

Read Article: Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us